BAT's Share Slide Sets Up a Test of Conviction Before Half-Year Update

British American Tobacco's stock ended last week on a sour note, shedding 116 pence to close at 4,591 pence on Friday — its weakest weekly finish in recent memory. The decline came despite a reaffirmed "Buy" rating and 5,750-pence price target from UBS, a gap of roughly 25% that highlights the growing disconnect between analyst conviction and market sentiment.

The sell-off capped a difficult five-day stretch. From May 22 to May 29, the shares lost around 6%, sliding from 4,880 pence in a steady erosion that saw daily closes of 4,820 pence, 4,770 pence, 4,710 pence, and finally 4,591 pence. Volume on Friday reached nearly 14.7 million shares, comfortably above the three-month average of 13 million, pointing to aggressive profit-taking after a strong May performance.

That monthly picture remains constructive: the stock ended April at 4,320 pence and May at 4,591 pence, a gain of just over 6%. The late-May retreat therefore looks more like a correction within an uptrend than a structural re-rating for a defensive FTSE 100 tobacco name. UBS is not alone in its optimism — Jefferies issued a "Buy" with a 5,200-pence target back in April, and among the six analysts tracked by MarketBeat, four rate the stock a buy, one a hold, and one a sell.

The Real Focus: Tuesday's Trading Update

The market's attention now shifts firmly to Tuesday, June 2, when BAT releases its pre-close trading update for the first half of the year. At stake is confirmation of the full-year guidance: currency-adjusted revenue growth of 3% to 5% and adjusted operating profit expansion of 4% to 6%. Both targets depend on two critical pillars — pricing power in the legacy cigarette business and accelerating momentum in the smokeless portfolio.

Should investors sell immediately? Or is it worth buying British American Tobacco?

On the cigarette side, the industry expects global volume declines of roughly 2% this year. BAT has historically offset such headwinds through aggressive pricing, and the market will watch closely whether that mechanism can continue to protect margins. The bigger driver of narrative, however, is the performance of "New Categories" — Vuse in vaping, glo in heated tobacco, and Velo in nicotine pouches. Management has targeted low-double-digit growth for this segment, and any sign of softening would undermine the entire smokeless transition thesis.

Buybacks and a Wellness Bet

BAT's capital return programme remains a key support for the equity story. The current buyback, running from April 23 to June 29, 2026, saw the company repurchase 562,557 shares between May 18 and May 22 via Merrill Lynch International, with plans to cancel the stock. After cancellation, the outstanding share count would fall to roughly 2.168 billion, with an additional 132.7 million shares held in treasury. The programme totalled £1.3 billion for 2026, providing a steady tailwind to earnings per share so long as the operating performance holds up.

Alongside the buyback, BAT continues to diversify beyond combustion. On May 28, the company converted a convertible debenture into equity of Charlotte’s Web Holdings, a Canadian specialist in hemp extracts. The conversion covered principal of CAD 75.3 million and interest of CAD 14.2 million, for a total of CAD 89.6 million (roughly USD 65 million), supplemented by a USD 10 million cash investment. BAT's stake in Charlotte's Web now stands at about 40%, marking a strategic push into wellness that bridges tobacco alternatives and non-nicotine consumer products.

Technical Territory and Key Levels

Despite the weekly slide, BAT's stock remains above both its 50-day moving average of 4,446.60 pence and its 200-day average of 4,367.26 pence, leaving the medium-term chart intact. The immediate support sits at Friday's intraday low of 4,554 pence, below which the 50-day line comes into play. On the upside, resistance is clustered between 4,659 pence (Friday's high) and 4,707 pence (the previous close). A recovery through that zone would improve the short-term setup, while a break below the 50-day would muddy the technical picture despite the favourable analyst backdrop.

British American Tobacco at a turning point? This analysis reveals what investors need to know now.

In euro terms, the stock closed at €52.66 on Friday, down 2.12% on the day and 6.37% over the trailing seven days. Over a month, it is still up 7.05%, and year-to-date it has gained 9.37%.

When markets open on Tuesday, three questions will dominate: Are the smokeless brands scaling fast enough? Can cigarette pricing hold the line? And is the buyback proceeding at a pace that reassures income-focused holders? If the answers align, last week's pullback will look like a brief pause in an otherwise resilient run.

Ad

British American Tobacco Stock: New Analysis - 30 May

Fresh British American Tobacco information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated British American Tobacco analysis...

en | GB0002875804 | BATS | boerse | 69446379 |